Awesome to see this story from our lab finally out! Shoutout to Grace Bower for making 4 new mouse lines just for revision experiments 🤯

I read this Cell paper that argues to have discovered a molecule (betaine) that mimics the geroprotective effects of exercise. This is a very valuable multi-omics resource, but the authors seemed to get caught in the rabbit hole of chasing a high-impact narrative🧵

congrats Evgeny Kvon Ethan Hollingsworth

People with #MultipleSclerosis using disease-modifying therapies have disproportionately high malignant melanoma reporting compared to all other medications. A disproportionality analysis of the FDA adverse event reporting system Harvard Medical School ▶️ journals.sagepub.com/doi/abs/10.117…

For 20 years, Catherine Doerfler experienced concerning symptoms but went undiagnosed until she came to UConn Health and was told she had #MultiplesSclerosis. Now Catherine is benefitting from a unique onboarding process facilitated by providers who specialize in #MS.

Congrats to our UConn Health MS center team for the video that explain our unique #MS onboarding process to new and second opinion patients from the #new england region, being implemented by our UConn outstanding team members.

The importance of patient-reported outcomes: A call for their integration in the routine care of patients with #MultipleSclerosis. Review from Mel Calvert CPROR Uni of Birmingham ▶️ journals.sagepub.com/doi/full/10.11…

#StemCells for #MS 💉New MS Living Well podcast 🎧 Pluchino lab - Regenerative Neuroimmunology & Mark S Freedman share latest on stem cell treatment; #AHSCT to neural stem cells! bit.ly/46gFi7U🍏apple.co/3IGjKaW MStranslate MS Views and News Klaus Schmierer🎗️🇺🇦 Celia Oreja-Guevara AnnekeVdWalt Jaime Imitola MD., FAAN

An international team of scientists has decoded some of the most stubborn, overlooked regions of the human genome. The recent study was published in nature and co-led by The Jackson Laboratory and UConn Health. today.uconn.edu/2025/07/the-mo…

"As I begin my term as President of the ISSCR, I am honored to serve this dynamic and forward-looking global community of stem cell researchers, clinicians, and innovators." Read the latest message from ISSCR President Hideyuki Okano: isscr.org/isscr-news/pri…

Lateral switching between ocrelizumab and ofatumumab does not affect effectiveness outcomes in #MultipleSclerosis, with some caveats over increased loss of IgG. Matched real-world cohort from Justus-Liebig-Universität Giessen ▶️ journals.sagepub.com/doi/full/10.11…

RT for clinician education: ISSCR with support of Harvard Medical School developed the first FREE clinician education course in stem cell medicine for ALL. If you are a nurse, medical student, or physician please visit learn.hms.harvard.edu/programs/stem-…. Ethan Hollingsworth UConn Health AAMC JAMA

🎉 We’re thrilled to present our August issue, which includes a Focus on immune aging! 🎉Here, you’ll find a series of reviews and opinion pieces on recent advances in immune aging research nature.com/nataging/volum… 🎨by Alex Whitworth

Women with MS are at higher risk of postpartum depression raising the importance of regular screening says a study in NeurologyLive®. Study lead Dr Riley Bove called for screening from late pregnancy - 12 months postpartum to aid detection/intervention. neurologylive.com/view/higher-le…

Grant submission deadline

Listen to the latest Stem Cell Report podcast episode to discover insights into tumor progression and potential treatments for one of the most aggressive brain tumors. ISSCR Yusha Sun Song and Ming Labs Penn Medicine ow.ly/H83H50WGCI8

“If your work addresses challenges beyond a single field, this is the place for it.” – Katherine Ognyanova, PNAS Nexus Reviewing Editor. Publish in our open access, interdisciplinary journal. Learn more: ow.ly/FI9g50WGFyj

🧠 To address the need for standardized quality assessment of cerebral organoids, researchers developed a Quality Control methodology for 60-day cortical organoids, evaluating five key criteria using a scoring system. 👉 Scientific Reports | go.nature.com/3JjHOAF

Will a simple skin biopsy soon help us nail the diagnosis of Dementia with Lewy Bodies (DLB)? A new study in Annals suggests we may be getting closer. Detecting phosphorylated alpha-synuclein in skin nerves showed 100% accuracy for identifying DLB in people with recent-onset